Clinical Trials Directory

Trials / Conditions / Pathological Myopia

Pathological Myopia

7 registered clinical trials studyying Pathological Myopia — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRetinal Clinical Assessment With AI-derived Quantitative Information
NCT07291960
Beijing Tongren Hospital—
Not Yet RecruitingAn Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
NCT06918028
Zhongshan Ophthalmic Center, Sun Yat-sen University—
UnknownPharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
NCT03128463
Xun Xu—
CompletedEfficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Seco
NCT01217944
Novartis PharmaceuticalsPhase 3
CompletedTreatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Ma
NCT00470977
Manhattan Eye, Ear & Throat HospitalPhase 1 / Phase 2
CompletedBevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular
NCT00407719
Johns Hopkins UniversityPhase 1
UnknownGenomewide Screening of Pathological Myopia
NCT00155753
National Taiwan University Hospital—